当前位置:首页 - 行情中心 - 人福医药(600079) - 财务分析

人福医药

(600079)

  

流通市值:314.81亿  总市值:332.97亿
流通股本:15.43亿   总股本:16.32亿

人福医药(600079)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润6.99亿元,每股收益0.33元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益2133646.44万元,未分配利润1012863.08万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产3716654.60万元,负债1583008.17万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入6,137,399,886.0525,435,484,349.4319,143,374,654.6412,861,283,334.71
营业总成本5,336,905,257.7922,665,868,260.2216,644,223,107.4511,126,432,608.62
营业利润857,303,978.422,522,028,5722,655,713,364.771,820,183,543.42
利润总额827,442,675.242,422,830,341.452,588,983,206.951,775,468,352.62
净利润698,615,043.071,778,342,930.442,107,380,778.331,455,630,352.46
其他综合收益-26,945,270.08132,562,352.95121,805,252.07-133,563,877.3
综合收益总额671,669,772.991,910,905,283.392,229,186,030.41,322,066,475.16
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计20,412,196,364.8319,858,374,856.8820,487,118,563.4920,071,470,540.7
非流动资产合计16,754,349,681.8216,649,949,124.8716,858,815,919.3916,509,346,129.14
资产总计37,166,546,046.6536,508,323,981.7537,345,934,482.8836,580,816,669.84
流动负债合计13,663,997,789.8113,339,976,221.9413,726,920,913.1813,389,312,998.64
非流动负债合计2,166,083,875.672,475,288,773.312,599,001,250.272,903,251,637.44
负债合计15,830,081,665.4815,815,264,995.2516,325,922,163.4516,292,564,636.08
归属于母公司股东权益合计18,134,575,571.2117,623,818,879.0817,868,500,039.8217,290,325,560.01
股东权益合计21,336,464,381.1720,693,058,986.521,020,012,319.4320,288,252,033.76
负债和股东权益合计37,166,546,046.6536,508,323,981.7537,345,934,482.8836,580,816,669.84
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计5,447,617,031.7324,697,293,034.1718,308,686,331.6312,147,484,207.84
经营活动现金流出小计5,784,396,672.3622,533,027,974.6816,816,007,878.5511,301,606,819.65
经营活动产生的现金流量净额-336,779,640.632,164,265,059.491,492,678,453.08845,877,388.19
投资活动现金流入小计9,230,501.69482,937,224.92269,348,256.87104,213,812.69
投资活动现金流出小计249,050,876.061,224,962,331.99957,208,979.32686,456,178.46
投资活动产生的现金流量净额-239,820,374.37-742,025,107.07-687,860,722.45-582,242,365.77
筹资活动现金流入小计2,335,229,393.439,860,935,168.76,897,401,726.375,010,304,510.19
筹资活动现金流出小计2,154,055,389.2911,358,932,530.737,861,473,395.935,750,501,167.48
筹资活动产生的现金流量净额181,174,004.14-1,497,997,362.03-964,071,669.56-740,196,657.29
汇率变动对现金及现金等价物的影响6,805,021.75-23,866,875.3-42,337,124.548,783,510
现金及现金等价物净增加额-388,620,989.11-99,624,284.91-201,591,063.47-467,778,124.87
期末现金及现金等价物余额2,502,199,269.152,890,820,258.262,788,853,479.72,522,666,418.3
最新报告期:2025-05-14
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
浙商证券盖文化,郭双喜1.351.641.892025-05-14
首创证券王斌1.281.581.892025-05-12
华源证券刘闯,李强1.461.601.762025-05-06
开源证券刘艺,余汝意1.391.601.862025-05-06
东吴证券朱国广1.361.631.872025-04-30
TOP↑